BC

Broadfin Capital Portfolio holdings

AUM $403M
This Quarter Return
-8.43%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$883M
AUM Growth
+$883M
Cap. Flow
-$35.2M
Cap. Flow %
-3.98%
Top 10 Hldgs %
52.81%
Holding
75
New
10
Increased
19
Reduced
14
Closed
13

Top Buys

1
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
$16.4M
2
VCYT icon
Veracyte
VCYT
$13.8M
3
HRTX icon
Heron Therapeutics
HRTX
$13.7M
4
TEVA icon
Teva Pharmaceuticals
TEVA
$12.6M
5
BCR
CR Bard Inc.
BCR
$9.03M

Top Sells

1
NVDQ
Novadaq Technologies Inc.
NVDQ
$33.8M
2
ANGO icon
AngioDynamics
ANGO
$23.9M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$18.9M
4
DVAX icon
Dynavax Technologies
DVAX
$14.1M
5
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
$13M

Sector Composition

1 Healthcare 90.7%
2 Financials 0.12%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$96.4M 10.71% 5,959,819 +456,637 +8% +$7.39M
PGNX
2
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$77.3M 8.59% 8,951,169 – –
TVTX icon
3
Travere Therapeutics
TVTX
$1.56B
$61.9M 6.87% 3,269,271 -200,000 -6% -$3.79M
HRTX icon
4
Heron Therapeutics
HRTX
$207M
$51.1M 5.67% 3,899,587 +1,049,587 +37% +$13.7M
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
$45.7M 5.07% 4,394,464 – –
ATRS
6
DELISTED
Antares Pharma, Inc.
ATRS
$30.2M 3.36% 12,971,093 -1,914,300 -13% -$4.46M
PETX
7
DELISTED
Aratana Therapeutics, Inc.
PETX
$26.5M 2.95% 3,695,442 +609,463 +20% +$4.38M
LJPC
8
DELISTED
La Jolla Pharmaceutical Company
LJPC
$26.5M 2.94% 1,510,316 +63,263 +4% +$1.11M
ENDP
9
DELISTED
Endo International plc
ENDP
$25.7M 2.85% 1,560,038 +105,500 +7% +$1.74M
SCTL
10
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$25M 2.77% 3,100,086 +650,000 +27% +$5.24M
ANGO icon
11
AngioDynamics
ANGO
$417M
$24.8M 2.76% 1,471,152 -1,419,527 -49% -$23.9M
TEVA icon
12
Teva Pharmaceuticals
TEVA
$21.1B
$23.5M 2.61% 647,500 +347,500 +116% +$12.6M
ARLZ
13
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$21.1M 2.35% 4,791,590 +384,600 +9% +$1.7M
IOVA icon
14
Iovance Biotherapeutics
IOVA
$807M
$18.3M 2.04% 2,638,259 – –
GNMX
15
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$17.5M 1.94% 3,370,306 – –
NVLN
16
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$16.4M 1.82% +1,948,554 New +$16.4M
MDCO
17
DELISTED
Medicines Co
MDCO
$14.8M 1.64% 436,400 +180,800 +71% +$6.14M
VCYT icon
18
Veracyte
VCYT
$2.39B
$13.8M 1.54% +1,788,266 New +$13.8M
DSCI
19
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$13.3M 1.48% 2,562,104 – –
TLGT
20
DELISTED
Teligent, Inc
TLGT
$12.8M 1.42% 1,931,711 -270,190 -12% -$1.79M
ACOR
21
DELISTED
Acorda Therapeutics, Inc.
ACOR
$12.1M 1.34% 644,153 +39,453 +7% +$742K
PRTK
22
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$12.1M 1.34% 786,134 – –
RXDX
23
DELISTED
Ignyta, Inc.
RXDX
$12M 1.33% 2,256,546 – –
DRRX icon
24
DURECT Corp
DRRX
$59.6M
$11.4M 1.27% 8,506,229 +2,111,023 +33% +$2.83M
ADXS
25
DELISTED
Advaxis, Inc.
ADXS
$10.9M 1.21% 1,519,259 -45,420 -3% -$325K
1
2 3